Cefixime 200 Mg Lactic Acid Bacillus Tablet

₹ 1,500/Box

Strength200 mg
FormTablet
Brand NameZicsef-200
ManufacturerFEMOWIN INDIA
Packaging Size10X10
Country of OriginMade in India
AvailabilityIn Stock
View in Hindi सेफिक्सिम 200 मिग्रा लैक्टिक एसिड बैसिलस टैबलेट
BACOFIX-200 LB is an advanced antibiotic tablet from Avosia Group, formulated with Cefixime 200 mg and Lactic Acid Bacillus (LB). This combination is widely prescribed for the treatment of bacterial infections such as respiratory tract infections, urinary tract infections, sinusitis, tonsillitis, bronchitis, and other infections of the ear, nose, and throat. Cefixime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Lactic Acid Bacillus helps restore and maintain healthy gut flora during antibiotic therapy, reducing the risk of diarrhea and other gastrointestinal disturbances.

Find products similar to Cefixime 200 Mg Lactic Acid Bacillus Tablet

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Product Image

Cefixime 200 Mg Lactic Acid Bacillus Tablet image 1Cefixime 200 Mg Lactic Acid Bacillus Tablet image 2Cefixime 200 Mg Lactic Acid Bacillus Tablet image 3

About the Company

GST Registration Date
May 2023
Legal Status of Firm
Limited Company
Nature of Business
Trader - Retailer
Number of Employees
11 To 25 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
May 2023
GST
06**********1ZF

Established in the year of 2023, We “Avosia Pharma Private Limited” are Wholesale Trader and Manufacturer of an Pharmaceutical Tablets, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, whose continual backing and direction have been useful to us for attaining exponential development in the current market.